Loading company…
Jiangsu biomedical company developing peptide and chemical drugs, with first-in-class peptide drug candidates.
Based in Jiangsu, China and established in 2009, Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., trading as ProteLight Pharma, researches and produces polypeptide and chemical drugs. Its pipeline includes first-in-class peptide drugs for anti-infection and anti-cancer uses, and it holds PCT and US/EU patents. In January 2025 it raised Series D funding from Guangzhou Cherami Sun Tour Equity Investment Management, Qingdao Guoxin Venture and Efung Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in